Deepinder Goyal commits $25 Mn to longevity venture Continue Research

Eternal founder and CEO Deepinder Goyal has committed $25 million from his personal wealth to expand his longevity venture, Continue Research. The project aims to explore ways to extend human life and improve overall health through research on ageing, nutrition, sleep, and mental wellness.

Continue Research, which began around two years ago, is not a conventional startup but a research-focused initiative and early-stage funding platform. According to Goyal, the fund will back scientists and entrepreneurs working on fundamental biological questions and health tracking technologies.

In a post on X, Goyal said the initiative is fully self-funded and intended to support researchers across the world. He described it as a long-term mission to understand human biology better and promote what he calls the “conscious evolution” of humanity.

Goyal added that the goal is to significantly improve human longevity and quality of life through sustained scientific exploration.

Continue Research will provide seed funding to early-stage teams working in the areas of ageing, health optimisation, and preventive wellness. The initiative plans to invest in projects that aim to slow or reverse aspects of biological ageing and help people live healthier for longer.

While Goyal continues to lead Zomato, Continue Research operates independently and is not linked to the company’s parent entity, Eternal. The move marks Goyal’s foray into the longevity and life sciences space, reflecting his growing interest in deep science and the long-term future of human health.